Meralys 1 Mg/Ml

Xylometazoline Hydrochloride, the active ingredient in Meralys 1 Mg/mL, is an imidazoline derivative presented as a 1 mg/mL nasal solution for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Meralys 1 Mg/mL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities worldwide, with a focus on quality and regulatory compliance. The product meets EU pharmacopeial standards and is manufactured under GMP conditions.

Xylometazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa, improving airflow.

- Common cold: alleviates nasal congestion by constricting dilated blood vessels in the nasal mucosa, providing rapid relief of a blocked nose. - Sinusitis: decreases mucosal edema in the sinus passages, helping to restore normal breathing and drainage. - Allergic rhinitis: reduces congestion caused by allergic inflammation, improving nasal patency during exposure to allergens.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal mucosa - Sneezing - Headache - Epistaxis (nosebleeds)

Serious or Rare Side Effects: - Severe hypertension - Tachycardia or arrhythmia - Allergic reactions such as rash, itching or swelling - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Nasal ulceration

When using Meralys, consider the following precautions to ensure safe and effective treatment.

- Use in children under 2 years: not recommended - Pregnancy: consult a healthcare professional before use - Existing hypertension or cardiovascular disease: use with caution - Concurrent use of monoamine oxidase inhibitors (MAOIs): avoid due to additive sympathomimetic effects - Prolonged use beyond 3 days: risk of rebound congestion; limit duration - Store at room temperature: keep in original container, protect from light and moisture

Xylometazoline Hydrochloride can interact with other medications, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - Oral decongestants such as pseudoephedrine: additive sympathomimetic activity may raise blood pressure - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis - Tricyclic antidepressants: may enhance cardiovascular stimulation

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia induced by the nasal spray - Antihypertensive agents: possible reduction in blood pressure control - Other intranasal medications: increased local irritation when used together